NEW YORK, Nov. 1, 2012 /PRNewswire/ -- Harwood Feffer LLP ( www.hfesq.com) is investigating potential claims against the board of directors of Schiff Nutrition International, Inc. ("Schiff" or the "Company") (NYSE: SHF) concerning the proposed acquisition of the Company by Bayer AG ("Bayer") in a transaction valued at approximately $1.2 billion.
On October 30, 2012, it was announced that Schiff and Bayer have entered into a definitive agreement pursuant to which Bayer will acquire Schiff. Under the terms of the transaction, Schiff shareholders will receive $34.00 in cash.
Our investigation concerns whether the Schiff board of directors is fulfilling its fiduciary duties, maximizing the value of the Company, disclosing all material benefits and costs, and obtaining full and fair consideration for Company shareholders.If you own Schiff shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact: Benjamin Sachs-Michaels, Esq. Robert I. Harwood, Esq.Harwood Feffer LLP488 Madison Avenue New York, New York 10022Phone Numbers: (877) 935-7400(212)935-7400Email: email@example.com Website: http://www.hfesq.com Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website ( http://www.hfesq.com) for more information about the firm. Attorney Advertising © 2012 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ( www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. SOURCE Harwood Feffer LLP